InCred has set a target price of Rs 2,821 on Mankind Pharma stock, marking an upside of 11%.

Discover Mankind Pharma's strategic shift to specialty therapies, targeting ₹2,821 amid growth challenges in acute segments.

Mankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This ...

BENGALURU, July 31 (Reuters) - India's Mankind Pharma (MNKI.NS), opens new tab posted first-quarter profit below expectations on Wednesday, as higher costs offset strong demand for its drugs. The ...

Get all latest & breaking news on Mankind Pharma. Watch videos, top stories and articles on Mankind Pharma at moneycontrol.com.

Nov 6 (Reuters) - India's Mankind Pharma (MNKI.NS), opens new tab reported a fourth straight quarter of profit fall on Thursday, as the government's sweeping cuts on its goods and services taxes ...

Quarterly Revenue: INR3,443 crore, up 11.8% year-on-year. Annual Revenue: INR14,278 crore, up 17.0% year-on-year. Quarterly Adjusted EBITDA Margin: 27.1%. Annual Adjusted EBITDA Margin: 25.4%.

BENGALURU, Oct 31 (Reuters) - India's Mankind Pharma MNKI.NS posted an over 19% rise in second-quarter profit on Tuesday, propelled by strong domestic sales and steady growth in the company's chronic ...

Mankind Pharma Ltd. is emerging as the frontrunner to acquire Bharat Serums & Vaccines Ltd. in a deal that could value the target company at around $1.5 billion, according to people with knowledge of ...

Mankind Pharma launches nationwide preventive oncology initiative: Our Bureau, Mumbai Thursday, June 25, 2026, 14:15 Hrs [IST] Mankind Pharma has launched a nationwide preventive ...

Domestic pharmaceutical major Mankind Pharma has joined hands with Armenian startup Denovo Sciences to launch an AI-led drug ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.